Fairmount Healthcare Fund II GP LLC, Director, 10% Owner at Viridian Therapeutics, Inc.\DE (VRDN), bought 454,545 shares at $22.00 ($10.0M) on 2025-10-23, disclosed to the SEC on 2025-10-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.